Follow-up visits by provider specialty for patients with major depressive disorder initiating antidepressant treatment.

Chen SY, Hansen RA, Farley JF, Gaynes BN, Morrissey JP, Maciejewski ML. Follow-up visits by provider specialty for patients with major depressive disorder initiating antidepressant treatment. Psychiatric services (Washington, D.C.). 2010 Jan 1; 61(1):81-5.

Related HSR&D Project(s)

• RCS 10-391 – Research Career Scientist

Dimensions for VA is a web-based tool available to VA staff that enables detailed searches of published research and research projects.

If you have VA-Intranet access, click here for more information vaww.hsrd.research.va.gov/dimensions/

VA staff not currently on the VA network can access Dimensions by registering for an account using their VA email address.    Search Dimensions for VA for this citation
* Don't have VA-internal network access or a VA email address? Try searching the free-to-the-public version of Dimensions

Search for Abstract from PubMed

---

Abstract:

OBJECTIVES: This study examined the association between provider specialty and guideline-concordant care after the initiation of antidepressant treatment. METHODS: Medical and prescription claims were analyzed from adults newly diagnosed as having major depressive disorder who initiated antidepressant treatment. Follow-up visits during the first 90 days after the index prescription were identified, and an indicator for receipt of guideline-concordant care (three or more visits) was created. Logistic regression models were used, and propensity score matching techniques were applied. Sensitivity analyses were conducted to investigate how results differed by varying the approach to identify follow-up visits. RESULTS: The study included 4,102 patients, and only 31% received guideline-concordant follow-up visits. Patients receiving their initial prescription from psychiatrists were nearly five times as likely as patients receiving their initial prescription from primary care providers to receive guideline-concordant follow-up care (odds ratio = 4.6, 95% confidence interval = 3.9-5.4). CONCLUSIONS: Routine care for antidepressant management falls short of guideline recommendations, especially in primary care.